HGG-23. DRUG SCREENING LINKED TO MOLECULAR PROFILING IDENTIFIES NOVEL DEPENDENCIES IN PATIENT-DERIVED PRIMARY CULTURES OF PAEDIATRIC HIGH GRADE GLIOMA AND DIPG
Alan Mackay(Institute of Cancer Research), Chris Jones(North Carolina State University), Jessica K.R. Boult(Institute of Cancer Research), Safa Al‐Sarraj(King's College Hospital), Jane Pears(Our Lady's Hospital), Andrew Martin(Clinica Universidad de Navarra), Fernando Carceller, Bassel Zebian(King's College London), Matthew Clarke(Institute of Cancer Research), Valeria Molinari(Institute of Cancer Research), Andrew S. Moore(Children's Health Queensland Hospital and Health Service), Samatha Hettige(St George's Hospital), Elisa Izquierdo(Institute of Cancer Research), Christopher Lord(Institute of Cancer Research), Ofelia Cruz(Hospital Sant Joan de Déu Barcelona), Sucheta Vaidya(Royal Marsden Hospital), Helen N. Pemberton(Institute of Cancer Research), Mariona Suñol(Hospital Sant Joan de Déu Barcelona), Sara Temelso(Institute of Cancer Research), Kathryn Taylor(Palo Alto University), Anna Burford(Cancer Research Institute of the Slovak Academy of Sciences), Diana Carvalho(Institute of Cancer Research), Jaume Mora(Hospital Sant Joan de Déu Barcelona), Rebecca F. Rogers(Institute of Cancer Research), Ketty Kessler(Institute of Cancer Research), Lynley V. Marshall(Royal Marsden Hospital), Francesca Del Bufalo, Henry Mandeville(Royal Marsden Hospital), Janat Fazal Salom(Institute of Cancer Research), Mariama Fofana(Institute of Cancer Research), Andrea Carai(Bambino Gesù Children's Hospital), Ángel M. Carcaboso(Hospital Sant Joan de Déu Barcelona), Carmen de Torres(Centro de Diseño, Arquitectura y Construcción), Simon P. Robinson(Institute of Cancer Research), Lynn Bjerke(Institute of Cancer Research), Leslie Bridges(St George's Hospital), Simon Stapleton(St George's Hospital), Angela Mastronuzzi(Bambino Gesù Children's Hospital), Christopher Chandler(University Hospitals Sussex NHS Foundation Trust), Maria Vinci(Cancer Research UK)
Cited by 1
Related Papers
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k